EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comparative Efficacy of Topical Clobetasol Propionate, Mometasone Furoate, and Manual Retraction in the Management of Phimosis in Children

Ray Ganapathy, Srinivasan Thiagarajan, Tharanidharan Sellamuthu, Hashini Dhinakaran, Thirunavukkarasu Arun Babu

Journal of Indian Association of Pediatric Surgeons · 2026-11 · 31 (6) · 988-995

DOI: 10.4103/jiaps.jiaps_156_26 ↗
AbstractBibliografische Angaben

Abstract

A BSTRACT Background: Phimosis is a common condition in children and is generally managed conservatively before surgical intervention is considered. Although topical corticosteroids are widely used, comparative evidence regarding the efficacy of different steroid preparations remains limited. Objectives: To compare the effectiveness of topical clobetasol propionate 0.05%, topical mometasone furoate 0.1%, and manual retraction alone in children with symptomatic phimosis. Methods: In this prospective study conducted at a tertiary care teaching hospital in South India, 119 boys aged 2–12 years with Kikiros grade 2–4 phimosis were allocated to receive topical clobetasol propionate 0.05%, topical mometasone furoate 0.1%, or manual retraction alone. Clinical assessments were performed at 2, 4, and 6 weeks. Treatment response was evaluated using changes in Kikiros grading. Results: At 6 weeks, complete response was achieved in 76.0% of children treated with clobetasol, 52.5% treated with mometasone, and 17.2% managed with manual retraction alone ( P < 0.001). Improvement was observed at all follow-up visits, with clobetasol demonstrating significantly higher response rates than mometasone and manual retraction. No treatment-related adverse effects were reported during the study period. Conclusions: Topical corticosteroid therapy was more effective than manual retraction alone for the management of symptomatic childhood phimosis. Clobetasol propionate 0.05% was associated with higher response rates than mometasone furoate 0.1%, supporting its use as an effective conservative treatment option. Further randomized controlled studies are warranted to confirm these findings.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →